
Elizabeth A. Brem, MD, highlights upcoming changes in the follicular lymphoma treatment paradigm that could move the field beyond chemotherapy.

Your AI-Trained Oncology Knowledge Connection!


Elizabeth A. Brem, MD, is an associate clinical professor of medicine at the University of California Irvine.

Elizabeth A. Brem, MD, highlights upcoming changes in the follicular lymphoma treatment paradigm that could move the field beyond chemotherapy.

Elizabeth Brem, MD, discusses data for odronextamab monotherapy in previously untreated patients with high-risk follicular lymphoma.

Published: January 7th 2025 | Updated: